Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL3897706 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL976623 | 0.97 | — | — | |
| SCHEMBL937334 | 0.97 | — | — | |
| Potassium Ion SCHEMBL3131828 | 0.95 | — | — | |
| Potassium Ion SCHEMBL5803916 | 0.84 | SLC34A1 (0.32) | — | |
| SCHEMBL9098975 | 0.80 | — | — | |
| Tetrabuthylammonium SCHEMBL2824667 | 0.77 | SLC22A1 (0.41) | — | |
| Potassium Ion SCHEMBL5689772 | 0.75 | — | — | |
| SCHEMBL6645670 | 0.75 | TSHR (0.38) | — | |
| SCHEMBL6998232 | 0.72 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105301118-B | A kind of detection method of mosapride citrate in relation to substance | 成都康弘药业集团股份有限公司 | 2018-05-25 | — | — | CN | claimed |
| CN-105301118-A | Mosapride citrate related substance detection method | CHENGDU KANGHONG PHARMACEUTICAL GROUP CO LTD | 2016-02-03 | — | — | CN | claimed |
| CN-114507127-A | Synthesis method of 2-keto pantoic acid | 中国科学院上海高等研究院 | 2022-05-17 | — | — | CN | disclosed |
| CN-110320289-A | Composition containing ACEI, the detection method in relation to substance | 南京优科生物医药研究有限公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-110320288-A | Composition containing ACEI, the method for separating and detecting in relation to substance | 南京优科生物医药研究有限公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-105301118-B | A kind of detection method of mosapride citrate in relation to substance | 成都康弘药业集团股份有限公司 | 2018-05-25 | — | — | CN | disclosed |
| CN-102365092-B | The burdock extract that arctigenin content is high and manufacture method thereof | KRACIE PHARMA, LTD. (JP) | 2016-05-11 | — | — | CN | disclosed |
| CN-105521771-A | Preparation method and use of boric acid affinity membrane | UNIV NORTHWESTERN | 2016-04-27 | — | — | CN | disclosed |
| CN-105301118-A | Mosapride citrate related substance detection method | CHENGDU KANGHONG PHARMACEUTICAL GROUP CO LTD | 2016-02-03 | — | — | CN | disclosed |
| EP-2620431-A1 | Novel crystals of substituted phenylalkanoic acid and production process | Asahi Kasei Pharma Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-2045244-B1 | NOVEL CRYSTAL OF SUBSTITUTED PHENYLALKANOIC ACID AND PRODUCTION PROCESS | ASAHI KASEI PHARMA CORP (JP) | 2013-04-03 | — | — | EP | disclosed |
| EP-0863874-B1 | PROCESS FOR PREPARING DIOXOAZABICYCLOHEXANES | PFIZER LTD (GB) | 2000-12-27 | — | — | EP | disclosed |
| EP-0818446-B1 | Process for preparing 2,4-dioxo-3-azabicyclo(3.1.0)hexanes | PFIZER LTD (GB) | 2000-11-02 | — | — | EP | disclosed |
| US-5917031-A | HEATING MIXTURE OF AT LEAST DEOXYCYTIDINE 5'-TRIPHOSPHATE OR DEOXYGUANOSINE 5'-TRIPHOSPHATE AND HEAT STABLE POLYMERASE FOR TIME FORMING POLYNUCLEOTIDES; SOLUTION HAS NO TEMPLATES OR PRIMERS | TAIKO PHARMACEUTICAL CO., LTD. (JP) | 1999-06-29 | — | — | US | disclosed |
| US-5847158-A | Process for preparing 2,4-dioxo-3-azabicyclo 3.1.0!Hexanes | PFIZER INC. (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0863874-A1 | PROCESS FOR PREPARING DIOXOAZABICYCLOHEXANES | Pfizer Limited (GB) | 1998-09-16 | — | — | EP | disclosed |
| EP-0818446-A1 | Process for preparing 2,4-dioxo-3-azabicyclo(3.1.0)hexanes | Pfizer Limited (GB) | 1998-01-14 | — | — | EP | disclosed |
| EP-0802258-A2 | Method of synthesizing polydeoxyribonucleotides, method of synthesizing chromosomal DNA and method of producing chromosomes | Taiko Pharmaceutical Co., Ltd. (JP) | 1997-10-22 | — | — | EP | disclosed |
| WO-1997019921-A1 | PROCESS FOR PREPARING DIOXOAZABICYCLOHEXANES | PFIZER LIMITED (GB) | 1997-06-05 | — | — | WO | disclosed |
| US-4704456-A | Process for sultamicillin intermediate | PFIZER INC. (US) | 1987-11-03 | — | — | US | disclosed |